Appointment and Treatment Tips: EYLEA® (aflibercept) Injection Appointment and Treatment Tips: EYLEA® (aflibercept) Injection

Appointment & Treatment Tips

Optimize your time with your eye care team with our appointment preparation tips. Plus, get more guidance on your treatment with helpful pointers.

MAKE EVERY APPOINTMENT COUNT

There are ways—before, during, and after—that can help you prepare for your appointments and get the most out of your treatment plan.

Tips to prepare for your appointment with your eye care team.

Before your appointment


Ask your eye doctor’s office how long the appointment will be. Arrange for someone to drive you to and from the appointment. You’ll also want a few things to bring with you to each appointment:

  • A list of questions. See a helpful list of questions, and don’t be afraid to ask them
  • A list of your prescribed and over-the-counter medicines you take and when you take them
  • Dark glasses. Your eyes may be sensitive to light afterwards
What to expect during your appointment.

During your appointment


Know what to expect at your appointment. Your doctor may:

  • Use tests to diagnose and check your condition or treatment
  • Discuss the EYLEA procedure with you
  • Examine, wash, and numb your eye
  • Check your eye pressure after the injection
What to expect after your appointment.

After your appointment


Now’s the time to relax.

  • You may have temporary visual problems. Do not drive or operate heavy machinery
  • You may have a temporary increase in eye pressure. Your doctor should check for this
  • Your eyes may be sensitive to light. Wear dark glasses
  • You may experience side effects. Contact your doctor right away

TREATMENT FOR WET AMD AND DME

View a video to learn more about EYLEA treatment for Wet Age-related Macular Degeneration (Wet AMD) and Diabetic Macular Edema (DME)/Diabetic Retinopathy (DR) in DME including before, during, and after the injection, in order to make the most of appointments with your eye care team.

RECOMMENDED DOSING

It’s important to keep up with your treatment schedule

  • DME
  • Wet AMD
  • MEfRVO
Recommended dosing/treatment schedule for EYLEA anti-VEGF treatment for DME, Wet AMD, and MEfRVO.

EYLEA is the only FDA-approved treatment for DME and DR in DME with a recommended dose of 2 mg administered by injection in the eye every 4 weeks (approximately every 28 days, monthly) for the first 5 injections, followed by injection once every 8 weeks (2 months). EYLEA may be dosed once per month, but in most patients, additional benefit was not seen with this dosing plan. Some patients may need monthly (every 4 weeks) dosing after the first 20 weeks (5 months).

After 5 initial monthly doses, some patients may need only half as many injections of EYLEA. Your eye care team will determine the EYLEA dosing schedule that's right for you.

Recommended dosing/treatment schedule for EYLEA anti-VEGF treatment for DME, Wet AMD, and MEfRVO.

EYLEA is the only FDA-approved treatment for Wet AMD with a recommended dose of 2 mg administered by injection in the eye every 4 weeks (approximately every 28 days, monthly) for the first 3 months, followed by injection once every 8 weeks (2 months). EYLEA may be dosed once per month, but in most patients, additional benefit was not seen with this dosing plan. Some patients may need every 4 week (monthly) dosing after the first 12 weeks (3 months). Although not as effective, patients may also be treated with 1 dose every 12 weeks after 1 year of effective treatment. Patients who have this dosing schedule should have their vision checked regularly. Your eye care team will determine the EYLEA dosing schedule that's right for you.

Your eye care team will want to see you regularly to check your vision and also check your treatment progress with EYLEA. Work with your eye care team to make sure you can keep your appointments and stay on your recommended treatment schedule.

Recommended dosing/treatment schedule for EYLEA anti-VEGF treatment for DME, Wet AMD, and MEfRVO.

The recommended dose of EYLEA for RVO is 2 mg administered by injection in the eye once every 4 weeks (approximately every 25 days, monthly).

Your eye care team will want to see you regularly to check your vision and also check your treatment progress with EYLEA. Work with your eye care team to make sure you can keep your appointments and stay on your recommended treatment schedule.

Learn about vision tests.

Monitoring your vision is important


Your doctor may use the following tests to diagnose and monitor your condition and check your treatment progress:

  • Visual acuity test Measures how well you see the letters on an eye chart from a distance.
  • Dilated eye exam Your doctor puts drops into your eye to dilate (widen) the pupil. He or she can then see the back of the eye, including the retina, for signs of problems or changes.
  • Fundus photography A special camera takes photos showing the inside of the back of the eye.
  • Fluorescein angiography Dye is used to show the blood vessels in the back of the eye.
  • Optical coherence tomography An imaging test that shows the layers and thickness of the retina.
Rides in Sight is a transportation-referral service.

Need a Ride? Rides in Sight can help

Regeneron Pharmaceuticals, the maker of EYLEA, supports Rides in Sight,* a transportation-referral service.

Learn more about Rides in Sight

Or call 1-855-607-4337

*Rides in Sight is not affiliated or related to EYLEA, EYLEA4U®, or Regeneron. Regeneron does not influence or control the operations of Rides in Sight and cannot guarantee assistance will be provided. Rides in Sight is not an emergency service. If you have an emergency, call 9-1-1.

EYLEA treatment tips

Tips on your treatment with EYLEA


  • Stick to your scheduled appointments. If you have to miss an appointment, reschedule as soon as possible
  • Follow all of your eye care team’s instructions. Your doctor is your primary source for information and treatment recommendations
  • Use the Amsler Grid at home to routinely check your vision. If you notice changes in your vision, call your doctor right away—don’t wait for your next office visit
Tips for caregivers of loved ones living with a retinal disease

Help care for your loved ones

Is someone you love living with a retinal condition? Get tips, information, and resources to help them.

Learn how to help

FINANCIAL SUPPORT FROM EYLEA4U®

SIGN UP FOR MORE INFORMATION

EYLEA4U® patient support program provides resources and financial assistance to help with EYLEA anti-VEGF treatment cost.

EYLEA4U is a comprehensive support program with several resources available to help eligible patients with the cost of EYLEA.

Sign up to receive information from EYLEA and receive a free pocket magnifier.

Get the latest materials and communications about EYLEA—and a complimentary pocket magnifier, too.

IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, moving spots in the field of vision, and increased pressure in the eye.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR) in patients with DME.

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2019, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

03/2019
US-LEA-14281f(1) US-LEA-14281f(1)

 

Searching with Lea

Close
MENU